Effects of Antidepressants on 5-HT7 Receptor Regulation in the Rat Hypothalamus

被引:0
|
作者
U Lena Mullins
G Gianutsos
AS Eison
机构
[1] Bristol-Myers Squibb Company,Department of Pharmaceutical Sciences
[2] Neuroscience Drug Discovery,undefined
[3] University of Connecticut,undefined
来源
Neuropsychopharmacology | 1999年 / 21卷
关键词
Serotonin; 5-HT; Antidepressants; SCN; Circadian rhythm;
D O I
暂无
中图分类号
学科分类号
摘要
Recent evidence suggests that a novel serotonin receptor 5-HT7 localized in the hypothalamus downregulates in response to treatment with the antidepressant fluoxetine (Sleight et al. 1995). This receptor has also been implicated in the regulation of circadian rhythms (Lovenberg et al. 1993). Here, we show that several agents administered in a profile consistent with activity at the 5-HT7 receptor produce significant functional Fos immunoreactivity in the suprachiasmatic nucleus (SCN), an effect reduced upon chronic exposure. Furthermore, binding studies demonstrate that chronic administration of Fos-inducing agents produces a neuroadaptive downregulation of the 5-HT7 receptor in the hypothalamus. The current studies extend the previous observations to include several pharmacologically distinct antidepressants. In addition, these studies provide further evidence to support the role of the 5-HT7 receptor in the mechanism of antidepressant action and in the regulation of circadian rhythms controlled by the SCN.
引用
收藏
页码:352 / 367
页数:15
相关论文
共 50 条
  • [21] Acute and repeated treatment with the 5-HT7 receptor antagonist SB 269970 induces functional desensitization of 5-HT7 receptors in rat hippocampus
    Krzysztof Tokarski
    Agnieszka Zelek-Molik
    Beata Duszyńska
    Grzegorz Satała
    Bartosz Bobula
    Magdalena Kusek
    Piotr Chmielarz
    Irena Nalepa
    Grzegorz Hess
    Pharmacological Reports, 2012, 64 : 256 - 265
  • [22] Impact of adrenalectomy on 5-HT6 and 5-HT7 receptor gene expression in the rat hippocampus
    Yau, JLW
    Noble, J
    Widdowson, J
    Seckl, JR
    MOLECULAR BRAIN RESEARCH, 1997, 45 (01): : 182 - 186
  • [23] The 5-ht7 Receptor is Essential for 5-ht-Induced Hypotension in the Doca Salt Hypertensive Rat
    Seitz, Bridget
    Fink, Gregory
    Watts, Stephanie
    HYPERTENSION, 2019, 74
  • [24] Differential effects of chronic clozapine and haloperidol on 5-HT2c and 5-HT7 receptor levels in the rat brain
    Clemett, DA
    Kendall, DA
    Marsden, CA
    Cockett, MI
    Fone, KCF
    BRITISH JOURNAL OF PHARMACOLOGY, 1997, 120 : P294 - P294
  • [25] The role of 5-HT7 Receptor in the pathogenesis of IBS
    Baicang Zou Lei Dong~* Yan Wang Shenghao Wang Mingbo Cao Department of Gastroenterology
    JournalofNanjingMedicalUniversity, 2007, (05) : 293 - 297
  • [26] NEUROCHEMISTRY, PHARMACOLOGY AND LOCALIZATION OF THE 5-HT7 RECEPTOR
    BRANCHECK, TA
    ZGOMBICK, JM
    ADHAM, N
    BARD, J
    DURKIN, M
    GUSTAFSON, E
    WEINSHANK, RL
    JOURNAL OF NEUROCHEMISTRY, 1995, 65 : S205 - S205
  • [27] Phosphorylation of the human 5-HT7(b) receptor
    Dover, TJ
    Monk, SA
    Barnes, NM
    Hope, AG
    BRITISH JOURNAL OF PHARMACOLOGY, 2003, 138 : U3 - U3
  • [28] Tetrahydrobenzindoles as selective 5-HT7 receptor antagonists
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1999, 4 (06) : 290 - 290
  • [29] Novel aminoethylbiphenyls as 5-HT7 receptor ligands
    Paillet-Loilier, Magalie
    Fabis, Frederic
    Lepailleur, Alban
    Bureau, Ronan
    Butt-Gueulle, Sabrina
    Dauphin, Francois
    Lesnard, Aurelien
    Delarue, Catherine
    Vaudry, Hubert
    Rault, Sylvain
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (11) : 3018 - 3022
  • [30] Tetrahydrobenzindoles:: Selective antagonists of the 5-HT7 receptor
    Kikuchi, C
    Nagaso, H
    Hiranuma, T
    Koyama, M
    JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (04) : 533 - 535